XPO1 inhibition modulates the Wnt/β-catenin signaling pathway to reduce colorectal cancer tumorigenesis.
Andrew E. Evans, Sahida Afroz, Alexa N. Magstadt, Anup Kasi, Dan A. Dixon
This paper shows Eltanexor, an XPO1 inhibitor, reduces COX-2 and Wnt/β-catenin signaling in CRC, decreasing tumor burden in Apcmin/+ mice.
Cancer Research Communications · Jul 1, 2025Peer-reviewedCancer Biology